Association of SNPs in the UGT1A gene cluster with total bilirubin and mortality in the Diabetes Heart Study

Atherosclerosis

Volumn 229, Issue 1, 2013, Pages 155-160

  Cox, Amanda J ^a   Ng, Maggie C Y ^a   Xu, Jianzhao ^a   Langefeld, Carl D ^a   Koch, Kenneth L ^a   Dawson, Paul A ^a   Carr, J Jeffrey ^a   Freedman, Barry I ^a   Hsu, Fang Chi ^a   Bowden, Donald W ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Bilirubin; Cardiovascular disease; Genetics; Vascular calcified plaque

Indexed keywords

BILIRUBIN;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CARDIOVASCULAR RISK; FEMALE; GENE CLUSTER; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; BILIRUBIN; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GLUCURONOSYLTRANSFERASE; HUMANS; MALE; MIDDLE AGED; MULTIGENE FAMILY; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; VASCULAR CALCIFICATION;

EID: 84879410515     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.04.008     Document Type: Article

References (30)

1. Vitek L. The role of bilirubin in diabetes, metabolic syndrome, and cardiovascular diseases. Front Pharmacol 2012, 3:55.
2. Schwertner H.A., Jackson W.G., Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem 1994, 40:18-23.
3. Hopkins P.N., Wu L.L., Hunt S.C., James B.C., Vincent G.M., Williams R.R. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler Thromb Vasc Biol 1996, 16:250-255.
4. Schwertner H.A., Vitek L. Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin. Atherosclerosis 2008, 198:1-11.
5. Vitek L., Jirsa M., Brodanova M., et al. Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis 2002, 160:449-456.
6. Novotny L., Vitek L. Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp Biol Med 2003, 228:568-571.
7. Tanaka M., Fukui M., Tomiyasu K., et al. Low serum bilirubin concentration is associated with coronary artery calcification (CAC). Atherosclerosis 2009, 206:287-291.
8. Moon J.S., Chang W.J., Lee C.H., et al. Relationship between serum bilirubin levels and coronary atherosclerosis in patients with type 2 diabetes. Korean Diabet J 2008, 32:338-345.
9. Ishizaka N., Ishizaka Y., Takahashi E., Yamakado M., Hashimoto H. High serum bilirubin level is inversely associated with the presence of carotid plaque. Stroke 2001, 32:580-583.
10. Neuzil J., Stocker R. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. JBiol Chem 1994, 269:16712-16719.
11. Lin J.P., O'Donnell C.J., Schwaiger J.P., et al. Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study. Circulation 2006, 114:1476-1481.
12. Vitek L., Schwertner H.A. The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases. Adv Clin Chem 2007, 43:1-57.
13. Bowden D.W., Lange L.A., Langefeld C.D., et al. The relationship between c-reactive protein and subclinical cardiovascular disease in the Diabetes Heart Study (DHS). Am Heart J 2005, 150:1032-1038.
14. Cox A.J., Agarwal S., Herrington D.M., Carr J.J., Freedman B.I., Bowden D.W. C-reactive protein concentration predicts mortality in type 2 diabetes: the Diabetes Heart Study. Diabet Med 2012, 29:767-770.
15. Harris E.H. Elevated liver function test in type 2 diabetes. Clin Diabet 2005, 23:115-119.
16. Dullaart R.P., Kappelle P.J., de Vries R. Lower carotid intima media thickness is predicted by higher serum bilirubin in both non-diabetic and type 2 diabetic subjects. Clin Chim Acta 2012, 414:161-165.
17. Chan K.H., O'Connell R.L., Sullivan D.R., et al. Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia 2013, 56:724-736.
18. Choi S.W., Lee Y.H., Kweon S.S., et al. Association between total bilirubin and hemoglobin A1c in Korean type 2 diabetic patients. JKorean Med Sci 2012, 27:1196-1201.
19. Bosma P.J., Chowdhury J.R., Bakker C., et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. NEngl J Med 1995, 333:1171-1175.
20. Raijmakers M.T., Jansen P.L., Steegers E.A., Peters W.H. Association of human liver bilirubin UDP-glucuronyltransferase activity with a polymorphism in the promoter region of the UGT1A1 gene. JHepatol 2000, 33:348-351.
21. Bielinski S.J., Chai H.S., Pathak J., et al. Mayo Genome Consortia: a genotype-phenotype resource for genome-wide association studies with an application to the analysis of circulating bilirubin levels. Mayo Clin Proc 2011, 86:606-614.
22. Johnson A.D., Kavousi M., Smith A.V., et al. Genome-wide association meta-analysis for total serum bilirubin levels. Hum Mol Genet 2009, 18:2700-2710.
23. Sanna S., Busonero F., Maschio A., et al. Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia. Hum Mol Genet 2009, 18:2711-2718.
24. Bosma P.J., van der Meer I.M., Bakker C.T., Hofman A., Paul-Abrahamse M., Witteman J.C. UGT1A1*28 allele and coronary heart disease: the Rotterdam Study. Clin Chem 2003, 49:1180-1181.
25. Bowden D.W., Cox A.J., Freedman B.I., et al. Review of the Diabetes Heart Study (DHS) family of studies: a comprehensively examined sample for genetic and epidemiological studies of type 2 diabetes and its complications. Rev Diabet Stud 2010, 7:188-201.
26. Bowden D.W., Lehtinen A.B., Ziegler J.T., et al. Genetic epidemiology of subclinical cardiovascular disease in the Diabetes Heart Study. Ann Hum Genet 2008, 72:598-610.
27. Carr J.J., Nelson J.C., Wong N.D., et al. Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development In young Adults (CARDIA) study. Radiology 2005, 234:35-43.
28. Carr J.J., Crouse J.R., Goff D.C., D'Agostino R.B., Peterson N.P., Burke G.L. Evaluation of subsecond gated helical ct for quantification of coronary artery calcium and comparison with electron beam ct. AJR Am J Roentgenol 2000, 174:915-921.
29. McArdle P.F., Whitcomb B.W., Tanner K., Mitchell B.D., Shuldiner A.R., Parsa A. Association between bilirubin and cardiovascular disease risk factors: using Mendelian randomization to assess causal inference. BMC Cardiovasc Disord 2012, 12:16.
30. Schooling C.M., Kelvin E.A., Jones H.E. Alanine transaminase has opposite associations with death from diabetes and ischemic heart disease in NAHNES III. Ann Epidemiol 2012, 22:789-798.